Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
Investec Structured Products are part of Calculus VCT. Worth noting that was a non exec director of Scancell until stepping down in 2018, Katherine Cornish-BowdenKate has acted as a consultant providing financial research to private equity and financial training firms and was appointed a director of Investec Structured Products Calculus VCT plc in February 2011.
Zak Mir's is a complete waste of space when it comes to predictions as nearly everyone knows.
His charts on AIM stocks are fantasy, always accentuating the rise to reel in the gullible who see huge profits but sadly it rarely happens. Scancell could be one of these rare Aim listed stocks that power ahead but it will be because of the science, not Zak Mir.
Big retrace throughout the day a bit unexpected, especially so much off she high.
The RNS didn't help, yet another PR mistake but I guess this is as expected from Scancell.
Where to now......Probably down as moneyflow was not that great indicating it was heavily traded but not fot long term investment.
Let's wait and see but I think it will go back to c15-18p.
AB124
I don't think C7 is going to answer your question so I will have a go and leave C7 to do the tick ups and trade volumes.
The SP is largely set by supply and demand with the supply of stock into that demand dictating how market makers will price the stock. The MM's will only hold a small number of shares so the price is set by PI's and II's requesting to buy or sell and the volume of the order.
For a company like Scancell the price will fluctuate without much attention to the fundamentals, similar to what we are seeing now. It makes no sense for a large capital raising to be done at 13p and now for the price to be 12p after climbing to near 20p. Except of course, the demand has fallen away and the drift lower is purely down to more sellers than buyers.
The Market Makers are not prepared o hold stock as that would be them taking a risk. They are primarily there to balance their books and make money from the spread.
Another factor to weigh is that market makers will set their price at a level which they know they will be able to both buy and sell stock. That just happens to be 11.69/11.99 at present. If there were no sellers, only buyers as C7 tries to indicate, the MM's would increase their sell and buy prices.
In a quiet spell, those holding a reasonable holding, let's say 500k can easily move the SP by selling in blocks of 50k or 100k as the MM's will lower the price to find the buyers to offset the orders. In this scenario both buy and sell prices might be impacted. So watch out for those who claim to be holding many shares, you probably know who they are.
Hope that helps.
Charts are not yet indicating a bearish move but as you can imagine all the Bullish momentum has gone with the moving averages now in neutral. Thursday 12th November saw the neutral position achieved so it looks like we are at the mercy of daily traders. The RSI is sitting on 37 slightly above oversold (30).
Clearly the SP has been hit with the news of others making significant progress with Covid vaccines while Scancell sleep walks into trials. Not sure why we are initiating a Phase 1 clinical trial known as COVIDITY during 2021. That seems a lost cause for momentum, market impact and SP value. I suppose we have to progress given the capital injection to do the research.
Do we really believe there is now a market for long term protection and that Scancell are leading the pack? I doubt it. Time will tell but it looks like Covid is a short term negative for those buying in at 13p and above. Question is, where is the bottom?